GlassScriptPhysician profile
Andrew M Futterman
NPI 1548780653
$38,221.10
in general payments reported to CMS, 2019-2025
22 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.25 · 2021: $15.77 · 2022: $1,156 · 2023: $27K · 2024: $10K · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Travel and Lodging: $5,472 · Food and Beverage: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,000.00 |
| Travel and Lodging | $5,471.82 |
| Food and Beverage | $1,559.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $36,726.04 | 2022-2024 | Gelpoint V-Path |
| Abbvie INC. | $268.47 | 2021-2025 | |
| Shield Therapeutics INC | $131.91 | 2023-2024 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $126.87 | 2022-2023 | |
| Astellas Pharma US INC | $122.96 | 2023-2024 | Veozah |
| Channel Medsystems, INC. | $118.92 | 2022-2023 | |
| Organon LLC | $94.53 | 2022-2024 | Nexplanon |
| Pfizer INC. | $82.87 | 2022-2024 | |
| Aspira Women'S Health INC | $77.37 | 2022-2023 | Ova1 |
| Hologic Sales and Service, LLC | $71.25 | 2022-2025 | Sentimag, Thinprep 2000 Processor, Aptima |
| Exeltis, USA INC. | $62.97 | 2023-2025 | Slynd |
| Sumitomo Pharma America, INC. | $58.70 | 2024 | Myfembree |
| Evofem Biosciences, INC. | $55.09 | 2022-2025 | Phexxi, Solosec, Phexx |
| Exact Sciences Corporation | $41.53 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $37.57 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $30.75 | 2022 | |
| Daiichi Sankyo INC. | $23.15 | 2022 | |
| Biogen, INC. | $21.38 | 2025 | Zurzuvae |
| Sage Therapeutics, LLC | $20.98 | 2022 | |
| Akebia Therapeutics INC | $18.25 | 2019 | |
| Axonics, INC. | $15.04 | 2024 | Axonics |
| Ethicon US, LLC | $14.50 | 2024 | Ethicon, Surgicel Nu-Knit, Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Futterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.